Epidemiology and Comparative Treatment Outcomes of patients with COVID 19 infection in Phra Nakhon Si Ayutthaya Hospital: A single center retrospective cohort study
Keywords:
COVID-19, percentage of cases, treatment outcome, mortality rate, COVID-19 pneumoniaAbstract
Background: COVID-19 infection is still a national problem of pandemic disease in Thailand due to a lack of effective therapy and inadequate vaccination. There were many times of outbreaks. However there is still very little study about epidemiology and treatment outcomes of COVID-19 infection in Thailand and by far there has been no study in Phra Nakhon Si Ayutthaya Hospital before. Therefore this study was conducted to collect data and fine the percentage and factors associated with mortality, length of stay, treatment and treatments outcome of COVID-19 infection in Phra Nakhon Si Ayutthaya Hospital.
Objective: To study the percentage of COVID-19 infection from all admitted patients in Phra Nakhon Si Ayutthaya in 4-month duration and compare treatment outcomes of COVID-19 pneumonia and non-pneumonia groups in patients with COVID-19 infection admitted in Phra Nakhon Si Ayutthaya Hospital between August to November 2021.
Method: This study is a retrospective cohort study that collected data from patients aged at least 18 years old who were admitted in Phra Nakhon Si Ayutthaya Hospital from August to November 2021, and diagnosed with COVID-19 infection by RT-PCR COVID-19 method. Epidemiologic and clinical data including gender, age, principal diagnosis, comorbidities, length of stay, treatments, outcome and related laboratory results were collected and analyzed using appropriate statistics to identify the percentage, mortality rate and compared treatment outcomes between pneumonia and non-pneumonia groups.
Result: Patients aged above 18 years old and diagnosed with COVID-19 infection who were admitted in Phra Nakhon Si Ayutthaya Hospital from August to November 2021 were 313 cases. After excluding patients who were not fit in inclusion criteria, a total of 273 patients were studied. There were 206 patients with COVID-19 pneumonia (75.5%), with mean age of 63 years. Of the total cases, there were 98 male cases (47.6%). The median length of stay is 15 days and the mortality rate is 30.1% (62 cases). There were 67 patients with non-pneumonia COVID-19 infection (24.5%), with mean age of 40 years, composed of 29 male cases (43.3%), a median length of stay of 15 days and a mortality rate of 1.5% (1 case). The study found that length of stay and mortality rate between pneumonia and non-pneumonia groups are statistical significantly difference.
This study showed that factors associated with the mortality rate are elderly, diabetes mellitus, heart disease, chronic obstructive pulmonary disease, chronic kidney disease and cerebrovascular disease. Multivariate analysis showed that the mortality rate in pneumonia groups was higher than non-pneumonia group 15.45 times.
Conclusion: The percentage of COVID-19 infection in Phra Nakhon Si Ayutthaya Hospital in 4 months is 12.73 and a significant difference of treatment outcome between COVID-19 pneumonia and non-pneumonia groups was found, including mortality rate and length of stay. When considered factors: elderly and some comorbidities, it is found that mortality rate in pneumonia group was higher than non-pneumonia group 15.45 times.
References
Rajatanavin N, Tuangratananon T, Suphanchaimat R, Tangcharoensathien V. Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Global Health 2021;6(7):e006178.
Ministry of Public Health Thailand. Thailand’s Experience In The COVID-19 Response [Internet]. 2020. [cited 2021 Oct 15]. Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/pub_doc/LDoc9.pdf
World Health Organization. Coronavirus disease (COVID-19) situation report [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Singhal T. A review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020;87(4):281-86.
Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol 2021;35:1-16.
Ali MJ, Hanif M, Haider MA, Ahmed MU, Sundas F, Hirani A, et al. Treatment options for COVID-19: a review. Front Med (Lausanne) 2020;7:480.
The National Institutes of Health (NIH). Coronavirus Disease 2019 (COVID-19) treatment guidelines [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Sirijatuphat R, Suputtamongkol Y, Angkasekwinai N, Horthongkham N, Chayakulkeeree M, Rattanaumpawan P, et al. Epidemiology, clinical characteristics and treatment outcomes of patients with COVID-19 at Thailand’s university-based referral hospital. BMC Infectious Diseases 2021;21(1):382.
Department of Medical Service, Ministry of Public Health. Thai national clinical practice guidelines for treatment of coronavirus disease 2019 25th June 2021 [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://covid19.dms.go.th/
Department of Medical Service, Ministry of Public Health. Thai national clinical practice guidelines for treatment of Coronavirus Disease 2019 21st July 2021 [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://covid19.dms.go.th/
Department of Medical Service, Ministry of Public Health. Thai national clinical practice guidelines for treatment of Coronavirus Disease 2019 4th Aug 2021 [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://covid19.dms.go.th/
Department of Medical Service, Ministry of Public Health. Thai national clinical practice guidelines for treatment of Coronavirus Disease 2019 9th Sep 2021 [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://covid19.dms.go.th/
Department of Medical Service, Ministry of Public Health. Thai national clinical practice guidelines for treatment of Coronavirus Disease 2019 2nd Nov 2021 [Internet]. 2021. [cited 2021 Nov 15]. Available from: https://covid19.dms.go.th/
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in corona virus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58(7):1021-28.
Pongpirul WA, Mott JA, Woodring JV, Uyeki TM, MacArthur JR, Vachiraphan A, et al. Clinical characteristics of patients hospitalized with coronavirus disease, Thailand. Emerging Infectious Disease 2020;26(7):1580-85.
Sivakorn C, Luvira V, Muangnoicharoen S, Piroonamornpun P, Ouppapong T, Mungaomklang A, et al. Case report: walking pneumonia in novel coronavirus disease (COVID-19): mild symptoms with marked abnormalities on chest imaging. Am J Trop Med Hyg 2020;102(5):940-2.
Nasomsong W, Luvira V, Phiboonbanakit D. Case report: dengue and COVID-19 coinfection in Thailand. Am J Trop Med Hyg 2020;104(2):487-9.
Thammathiwat T, Tungsanga S, Tiankanon K, Torvorapanit P, Chumpangern W, Udomkarnjananun S, et al. A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient. Transpl Infect Dis 2021;23(1):e13388.
Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Preventive Medicine Association of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ เป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไปและผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง